Kelonia Therapeutics

1 follower

Kelona is revolutionizing gene delivery to expand the impact of genetic medicines.

Their goal is to develop a new wave of accessible genetic medicines that will transform the lives of patients suffering from a broad range of conditions.

Industries

Employees

11-50

Links


Org chart

Kevin Friedman
Chief Executive Officer
Collapse
Travis Quigley
SVP, Clinical Development
Laura Sandler
SVP, Strategic Operations
Sarah Tannehill-Gregg
Vice President, Preclinical Development
M. Travis Quigley
SVP. Clinical Development, Technical Development Operations, and Program and Alliance Management
James Rottman
Senior Vice President and Head of Research
Michael McDonald
Senior Vice President, Head of Intellectual Property and Legal Affairs
Charlene Stern
Chief Business Officer

Board & advisors

Michael Birnbaum
Board Member
Bob More
Board Member
Bryan Roberts
Board Member